How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1135
https://www.valueinhealthjournal.com/article/S1098-3015(13)03040-4/fulltext
Title :
How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03040-4&doi=10.1016/j.jval.2013.08.1135
First page :
A501
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
993